Company description
Developability refers to the possibility for the successful development of a lead candidate into a stable, safe, manufacturable, and efficacious drug, which is enable to be used as an additional selection criterion. By using a class of small-scale, fast, and predictive tests addressing biochemical and biophysical features, as well as in silico analysis, enable to evaluate a clinical candidate molecule with promising properties at an early stage of drug development. With years of exploration in antibody engineering, Creative Biolabs has built a full-scale in silico technology platform. Based on our advanced platform, we offer high quality antibody developability prediction services for customers all over the world, including Antibody Aggregation Prediction and Antibody Immunogenicity prediction.
